Pharmacodynamic Modeling of Anti-Cancer Activity of Tetraiodothyroacetic Acid in a Perfused Cell Culture System
Figure 3
Tetrac suppresses proliferation of glioma and breast cancer cells.
U87MG cells (A) and MDA-MB-231 cells (B) were treated with different constant concentrations of tetrac (10−9 to 10−5 M). Cells were harvested and counted at intervals as indicated. Total cell numbers from each treatment were used as indicators of tetrac-induced anti-proliferation. Multiple observations at each time point are multiple cell counts from one experiment.